Brief: Unicycive Therapeutics Says On July 25, Got Notice From Nasdaq, Regained Compliance With Minimum Market Value Requirement For Continued Listing
26/07/2023 11:17
July 26 (Reuters) - Unicycive Therapeutics Inc UNCY.O :
* UNICYCIVE THERAPEUTICS- ON JULY 25, GOT NOTICE FROM
NASDAQ,
REGAINED COMPLIANCE WITH MINIMUM MARKET VALUE REQUIREMENT FOR
CONTINUED LISTING
Further company coverage: UNCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unicycive Therapeutics
See all newsBrief: Unicycive Therapeutics Appoints Meredith Manning To Board Of Directors
Brief: Unicycive Therapeutics Announces Resubmission Of New Drug Application For Oxylanthanum Carbonate
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
Unicycive rises on narrower quarterly loss